Search Results 401-410 of 16989 for monoclonal antibody

1. Clinical trials - Oncology (Medical)

   Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...

2. Select thyroid clinical trials at Mayo Clinic

   ... monoclonal antibody with the goal of decreasing TSH receptor antibody levels by 70% to 80%. Enrolled patients will be evaluated jointly by Mayo Clinic ...

3. Vorinostat, Temozolomide, or Bevacizumab in Combination with Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients with Newly Diagnosed High-Grade Glioma - Mayo Clinic

   Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...

4. Hypereosinophilic Syndrome Clinical Trials - Mayo Clinic Research

   Mepolizumab is a humanized monoclonal antibody. In conditions where eosinophilia is considered to play an important part in the pathology, including ...

5. Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

6. Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma - Mayo Clinic

   RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some find cancer cells and help kill them or carry cancer ...

7. Wilms Tumor Clinical Trials - Mayo Clinic Research

   Antibody-drug conjugates, such as lorvotuzumab mertansine, are ... Monoclonal antibodies, such as cixutumumab, can block tumor growth in different ways.

8. Obinutuzumab With or Without PI3K-delta Inhibitor TGR-1202, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma - Mayo Clinic

   Monoclonal antibodies, such as obinutuzumab, may interfere with the ability ... antibody), as measured from the last dose of bendamustine; relapsed ...

9. Trial of Sequential Treatment of Multiple Myeloma with Antibody Therapy - Mayo Clinic

   ≥ Grade 3 neuropathy and/or POEMS syndrome (plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes).

10. Clinical trials - Oncology (Medical)

    Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ...